The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A Single Center, Randomized, Double-blinded, Placebo-controlled, Open-label, Positive-controlled, Four-way Crossover Study to Assess the Effect of a Single Oral Dose NKTR-118 Administration on QTc Interval Compared to Placebo, Using AVELOX (Moxifloxacin) as a Positive Control, in Healthy Male Subjects
- collapse Secondary Prevention Treatment in patients who have suffered a cardiovascular event.
- collapse Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin
- collapse Long-Term follow-up of antithrombotic management patterns in acute coronary syndome patients in Asia
- collapse Statins Use Patterns in Spain
- collapse An Efficacy and 2-Year Safety Study of Open-label Rosuvastatin in Children and Adolescents (Aged From 6 to Less Than 18 Years) With Familial Hypercholesterolaemia
- collapse A phase III, Multi-center, randomized, Double-blind, placebo-controlled, parallel-group factorial study of Metaprolol Succinate extended release tablets (TOPROL-XL) Hydrochlorothiazide and their combination in patients with essential hypertension.
- collapse Dose Ranging, Safety and Tolerability of TOPROL-XL (metoprolol succinate) Extended-release Tablets (metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Study.
- collapse A Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL (metoprolol succinate) Extended-release Tablets (metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Open-Label Extension of Protocol 307A.
- collapse Reversal of Ventricular Remodeling With Toprol-XL
